eISSN: 1897-4252
ISSN: 1731-5530
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2008
vol. 5
 
Share:
Share:

Torakochirurgia
Recurrent malignant solitary fibrous tumour of the pleura – a case report of a delayed diagnosis

Łukasz Gąsiorowski
,
Wojciech Dyszkiewicz
,
Mariusz Kasprzyk

Kardiochirurgia i Torakochirurgia Polska 2008; 5 (3): 301–302
Online publish date: 2008/09/11
Article file
- Recurrent.pdf  [0.13 MB]
Get citation
 
 

Introduction

Malignant solitary fibrous tumours (SFTs) of the pleura are extremely rare. They account for approximately 12 to 40% of the entire SFT entity, which is itself an uncommon thoracic neoplasm [1, 2]. Previously classified as a benign form of mesothelioma, they have a variable potential for malignancy. Based on the mitotic activity, nuclear pleomorphism and the degree of cellularity, this potential can be estimated, thus requiring a close clinical follow-up.
We report a case of a 54-year-old previously healthy female presenting with short episodes of confusion. She had no other symptoms. During a work-up a chest X-ray was done, revealing a huge mass in the right lung (Fig. 1a). A CT scan was performed, confirming a giant 17 cm mass, shifting the mediastinal structures to the left side (Fig. 1b). The mass was partially infiltrating the descending aorta. The mediastinal lymph nodes were not enlarged. Fibreoptic bronchoscopy revealed a rotated, narrow bronchial lumen in the left bronchial tree. The episodes of confusion were linked to hypoglycaemia. Since the biopsies taken during bronchoscopy and transthoracic biopsies were negative,
a decision to perform diagnostic VATS was made. The frozen section of the biopsy was positive for small cell cancer and the procedure was terminated. A week later however, the final pathology came back as a solitary fibrous tumour. The cells were found to be immunoreactive for CD34, vimentin and Ki67, supporting a mesenchymal origin of the mass. Subsequently, a thoracotomy was performed and a giant encapsulated tumour weighing 2450 g was encountered. The tumour was infiltrating the lung parenchyma (Fig. 2). The radical removal required a middle lobectomy. The post-operative period was uneventful and there were no more episodes of hypoglycaemia. During a routine 6-month follow-up CT of the chest was done, revealing a recurrent mass in the right hilum. The patient, however, still being asymptomatic, declined further intervention and disappeared from the clinic. She returned a year later with symptoms of persistent cough and a repeat CT scan showed progression of the tumour. Rethoracotomy was performed and a recurrent 10 × 8 cm mass was found. A radical resection required
a right pneumonectomy. The postoperative period was uneventful and the patient was discharged on POD #8.
A follow-up CT scan 12 months later showed no signs of recurrence and the patient remains asymptomatic.


Comment

Our case is unique because of the mass size, symptomatology and the pattern of recurrence. Most patients present with dramatic symptoms of dyspnoea, chest pain and cough. The presented patient in spite of the giant size of the tumour had only symptoms consistent with hypoglycaemia. The incidence of hypoglycaemia is estimated as 14% [1]. In spite of grossly radical resection a relatively fast recurrence was found. Unfortunately, the follow-up was interrupted by the patient, who did not want any intervention at that time. Although the repeat resection required a pneumonectomy,
a good outcome was achieved. The tumour arose from the visceral pleura, requiring a resection of the involved lung parenchyma. This is consistent with the majority of reported cases [2].
SFT of the pleura can show a wide spectrum of histological features. The majority of previously reported tumours are benign in origin [1–3]. Local recurrence is typical only in the malignant variant [4]. Although a radical resection is still the mainstay of therapy, it is still unclear whether there is any role for neoadjuvant or adjuvant therapy. Patient follow-up is mandatory as the tumour’s behaviour is unpredictable [5].


References

1. Rena O, Filosso PL, Papalia E, Molinatti M, Di Marzio P, Maggi G, Oliaro A. Solitary fibrous tumour of the pleura: surgical treatment. Eur J Cardiothorac Surg 2001; 19: 185-189.
2. Briselli M, Mark EJ, Dickersin GR. Solitary fibrous tumors of the pleura: eight new cases and review of 360 cases in the literature. Cancer 1981; 47: 2678-2689.
3. de Perrot M, Fischer S, Brundler MA, Sekine Y, Keshavjee S. Solitary fibrous tumors of the pleura. Ann Thorac Surg 2002; 74: 285-293.
4. Magdeleinat P, Alifano M, Petino A, Le Rochais JP, Dulmet E, Galateau F, Icard P, Regnard JF., Solitary fibrous tumors of the pleura: clinical characteristics, surgical treatment and outcome. Eur J Cardiothorac Surg 2002; 21: 1087-1093.
5. Chang YL, Lee YC, Wu CT. Thoracic solitary fibrous tumor: clinical and pathological diversity. Lung Cancer 1999; 23: 53-60.
Copyright: © 2008 Polish Society of Cardiothoracic Surgeons (Polskie Towarzystwo KardioTorakochirurgów) and the editors of the Polish Journal of Cardio-Thoracic Surgery (Kardiochirurgia i Torakochirurgia Polska). This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.